RetInSight is at the forefront of innovative digital health companies developing best-in-class AI software solutions for healthcare applications. As a result, RetInSight is constantly on the move. Every day we take steps that bring our AI solutions closer to eye care professionals, patients and payors. Here you can keep yourself informed of our accomplishments.
Contact Kilabs KILABS srlMichelangelo Simonelli, CEOVia Zoe Fontana, 220 Unità 2B CAP 00131Roma, ItalyE-Mail: info@kilabspharma.it Media Contact...
RetInSight is revolutionizing diagnosis and therapy in medicine with AI technology. In ophthalmology, our software enables precise diagnosis of age-related macular...
Vienna, 2024, July 10th – RetInSight, a pioneer in AI-based image analysis of retinal diseases, and veonet, a leading network of ophthalmology care centers in several...
Leading the charge in redefining eye care, the innovative I-SCREEN project is tackling age-related macular degeneration (AMD), the predominant cause of severe...
Video
In this episode of the IEMO VideoPodcast, Prof. Paolo Lanzetta is interviewing Prof. Ursula Schmidt-Erfurth on Artificial Intelligence (AI) and how it will bring about...
Elevate nAMD management with precision using the Progression Feature in the RetInSight Fluid Monitor, allowing for enhanced disease monitoring and precise visualization...
Vienna, 2023, Nov. 9th – RetInSight, an Austrian company, leading in the field of artificial intelligence (AI)-based image analysis of retinal diseases, announces...
In this Healio Video Perspective, Ursula Schmidt-Erfurth, MD, speaks about OCT-based artificial intelligence analysis for the management of geographic atrophy, a topic...
In Retina Today Stela Vujosevic, MD, Department of Biomedical, Surgical and Dental Sciences, University of Milan and Head, Medical Retina Unit, University Eye Clinic, San...
In this recent case report, Valentina Sarao, MD, Daniele Veritti, MD and Paolo Lanzetta, MD, of the Department of Medicine-Ophthalmology, University of Udine and Istituto...
Many thanks to Dr. Pierre-Henry Gabrielle of CHU Dijon Bourgogne for presenting his views on the monitoring of nAMD with the RetInSight Fluid Monitor in a fully occupied...
Thank you to the 2023 Houska Prize Jury for recognising our achievements in the development of OCT-based AI-software for Age-related Macular Degeneration by nominating...
It was good to see you at ARVO 2023 in New Orleans, USA. If you missed the presentations about our algorithms for the monitoring of nAMD ad geographic atrophy, you can...
At this year’s EURETINA in Hamburg, Germany, there were several engaging presentations ...
Regulatory approval of a novel artificial intelligence-based tool that provides precise measurement of retinal fluid may introduce major paradigm changes in the...
Heidelberg Engineering is expanding its healthcare IT portfolio with the introduction of Heidelberg AppWay. This latest addition to the company’s ecosystem offers...
First in class AI-based “fluid activity meter” in nAMD obtains CE Mark
RetInSight, a leader in AI-assisted retinal biomarker image analysis, has received its EU Quality Management System certificate according MDR 2017/745 on December 13,...
Heidelberg Engineering GmbH and RetInSight GmbH intend to interface the RetInSight AI-based fluid monitor application with the Heidelberg Engineering product portfolio,...
Topcon Healthcare of Oakland, NJ, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will partner...